Candesartan cilexetil (GW615775, Test formulation)

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Hypertension

Phase 1

Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions

CompletedNCT02006602

GlaxoSmithKlineHypertension

Start: 2013-12-13End: 2014-01-22Updated: 2018-03-08

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

CompletedNCT02006589

GlaxoSmithKlineHypertension

Start: 2013-12-11End: 2014-01-22Updated: 2017-05-15